Skip to content

The Investigation of Medication Adherence and Disease Management in Elderly Patients with Multimorbidity

The Investigation of Medication Adherence and Disease Management in Elderly Patients with Multimorbidity

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095124
Enrollment
Unknown
Registered
2025-01-02
Start date
2025-01-11
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Coronary Heart Disease, Dyslipidemia, Diabetes Mellitus

Interventions

Intervention group:Community standard disease management + Personalized health education and medication reminders + Multi-level follow-up and personalized health management.
control group:Community standard disease management

Sponsors

The First Affiliated Hospital of Xian Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 88 Years

Inclusion criteria

Inclusion criteria: 1) Diagnosed with two or more common cardiovascular diseases (hypertension, coronary heart disease, dyslipidemia, diabetes); 2) Aged 60 years or above; 3) Have been taking at least one medication for chronic disease for at least three months prior to inclusion in the study; 4) Able to use basic phone functions (calls, text messages, etc.); 5) Capable of independently managing their current medications; 6) Clear consciousness, able to live independently and cooperate, with stable condition; 7) Have sufficient physical ability to perform basic therapeutic exercises; 8) Have basic reading, writing, listening, and speaking abilities for effective communication; 9) Able to provide written informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1) Recent history of serious illness (e.g., heart failure, myocardial infarction within the past 3 months, coronary artery bypass surgery or coronary revascularization, unstable angina, or uncontrolled severe arrhythmia, severe chronic obstructive pulmonary disease, cancer requiring surgery, radiotherapy, or chemotherapy); 2) Life expectancy of less than 12 months; 3) Placement in a nursing home or long-term care facility; 4) Planning to leave the community within the next 6 months; 5) Cognitive impairment or severe mental health issues; 6) Currently participating in another study related to chronic disease management.

Design outcomes

Primary

MeasureTime frame
Medication Possession Ratio;Medication Persistence;Medication adherence;

Secondary

MeasureTime frame
Blood pressure;Glycosylated haemoglobin;Low-density lipoprotein cholesterol;Triglycerides;Total cholesterol;High-density lipoprotein cholesterol;Height;Weight;NYHA classification of cardiac function;

Countries

China

Contacts

Public ContactFeng Bianling

Medical Department, Xi'an Jiaotong University; The First Affiliated Hospital of Xian Jiaotong University

fengbianling@163.com+86 153 0926 9476

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026